REAL-WORLD SINGLE CENTER USE OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS, INCLUDING THOSE REFRACTORY TO FIRST-GENERATION JAK INHIBITORS-MedSci.cn

REAL-WORLD SINGLE CENTER USE OF UPADACITINIB IN RHEUMATOID ARTHRITIS PATIENTS, INCLUDING THOSE REFRACTORY TO FIRST-GENERATION JAK INHIBITORS

Kamiya, M; Mori, S; Yamazaki, K; Oka, N; Shoukaku, N; Togawa, D

ANNALS OF THE RHEUMATIC DISEASES, 2023; 82 (): 1430

科室
- - 订阅+
  - 更多科室
工具
服务